NECA in the Know
NECA in the Know
Episode 179: What Happens When Treatment is Interrupted?
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
This week, Marianna sits down with Carolyn Chu and Astha Kanani from the National Clinician Consultation Center (NCCC) to talk about treatment interruptions when it comes to HIV and Hepatitis C or HCV. Learn about why this can happen, the impact on treatment outcomes, and what you as an HIV care provider can do to prevent them.
--
Reach out to the NCCC at 844-ASK-NCCC or 844-275-6222.
Learn more at nccc.ucsf.edu.
Resources mentioned in this episode:
Dannenberg C, Matthews H, Hüfner A, et al. Long-term real-world use of cabotegravir/rilpivirine: adherence and virological efficacy over a 44-month observation period. Infect Dis Ther. 2025:14(8):1775-1797.
De La Hoz A, Pooja A, Kancharla A, et al. Characteristics and outcomes of direct-acting antiviral experienced patients with hepatitis C undergoing retreatment at an essential hospital in the United States. Open Forum Infect Dis. 2024;11(12):ofae704.
--
Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=AQX7941)
--
Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes.
--
Check out our free online courses: www.necaaetc.org/rise-courses
--
Download our HIV mobile apps:
Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=US
Apple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691